DME competitive bidding
This article was originally published in The Gray Sheet
Executive Summary
Diabetes product manufacturers favor administrative route over legislation to convince CMS that glucose monitors are sufficiently distinct from other durable medical equipment, prosthetics, orthotics and supplies to be omitted from products eligible for competitive bidding when the agency releases a notice of proposed rulemaking this summer. CMS' Program Oversight & Advisory Committee meets in Baltimore Feb. 28-March 2 to mull recommendations for implementing the program. Diabetes management firms also will work with Secretary of Veterans Affairs Jim Nicholson, sworn in Feb. 1, against procurement standardization of the products (1"The Gray Sheet" July 5, 2004, p. 3)...
You may also be interested in...
Diabetes Management Firms Shun VA Medical Product Standardization
Diabetes testing equipment manufacturers are uniting to dissuade the Department of Veterans Affairs from issuing a request for proposals (RFP) that would standardize clinical preference products nationwide
Deal Watch: AbbVie Teams With MedinCell On Long-Acting Injectables
Collaboration Edition: Including deals involving Evotec/Variant, Sanofi/IGM/Nurix, ABVC/OncoX and Harmony/Bioprojet, along with tech transfer agreements and deals in brief.
GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health
Voluson Signature 20 and 18 ultrasound provides clinicians with workflow efficiencies in detecting female reproductive health problems, especially those related to pregnancy.